Skip to content

MOVE

Active Non-profit associationfounded 2020active for 6 yearsBoulevard de Patience et Beaujonc 9, 4000 LiègeKBO/BCE: BE 0744.592.190
MOVE
Follow ReportCompare

Overview

Lifetime

6 annual accounts with figures on one time axis
peak €259,631 (2020)
€257,018▲ 47.4%
lowest -€397,064 (2022)
€184,686▲ 186%
peak €417,601 (2021)
€334,565▲ 123%
€171,800▼ 49.4%
peak 1 FTE (2022)
0.7 FTE▼ 30.0%
Board31 names since 2020all names
20 directorsChristianKrings and 19 others
Documentsfilings and deeds
09-07-202622 days before the deadline
2025financial year
Gross margin from €174,344 to €257,018Result from €64,615 to €184,686Staff from 1 FTE to 0.7 FTEEquity from €149,879 to €334,565Debts from €339,774 to €171,800Cash from €294,936 to €165,302

Key points

from the 2025 annual accounts

Result

€184,686 ▲ 186%
€64,6002024€185,0002025

The result rose in 2025 from €64,615 to €184,686.

Turnover

≈ €440,000 estimated

The accounts state no turnover.

Payment terms

132 days to suppliers
Suppliers
337 to 132

MOVE pays its suppliers 205 days earlier than in 2024.

Liquidity

2.95 was 1.44 in 2024

Short-term debts fell from €339,774 to €171,503.

Filings

6 annual accounts 2 late
AprilJune31 JulyOctober202020222024

The 2020 accounts came latest: 331 days after the end of the period.

Checked score

96
Excellent
Financially stronger than 71% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value

Financial strength
Strong

91+35equity 66.1% of total assets
76+13short-term debt 33.9% · cash 32.6%
100+30return on assets 36.5%

Score breakdown

lowers risk
Legal form: non-profit association
Sector: Human health activities (NACE 86)
Liquidity: current ratio 2.95, cash €165,302
Equity €334,565 (66.1% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 54% of them on solvency, 57% on liquidity, 80% on profitability and 92% on growth.

The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as MOVE has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.4%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of MOVE itself is lower: < 0.1% within 12 months. It rests on far more data about MOVE than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for MOVE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €30,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 2.95 (1.44 in 2024), above the usual 1.5. Short-term debt is 33.9% and cash 32.6% of total assets. 33.9% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

6 signals, none raises the risk
Six signals.
lowers riskneutral
lowers risk · Legal form: non-profit association
KBO
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.95, cash €165,302
NBB · annual accounts
lowers risk · Equity €334,565 (66.1% of total assets)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
202122232425
2020 to 2025 · latest year €334,565
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
22 days early
2024
30 days early
2023
20 days early
2022
51 days late
2021
33 days early
2020
331 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 46 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

XD
Xavier Drion
Chair
CN
Claudia Niessen
Director
JB
Joseph Backes
Director
CM
Christian Maréchal
Director
JM
Jean-Marie Bertrand
Director
TW
Thierry Wimmer
Director
and 14 othersBoard & ownership

Recent changes

3 directors reappointed Xavier Drion (chair), Claudia Niessen (vice-chair) and Joseph Backes (vice-chair) · Board meeting of 26-02-2024 · Gazette deed
1 director appointed, 14 reappointments Appointment: Jean-MarieBertrand · Reappointments: JosephBackes, PierreBaratto, Jean-MarieBertrand, ElisabettaCallegari, MicheldeLamotte, XavierDrion and 8 others · General meeting of 21-12-2023 · Gazette deed
4 directors appointed, 4 resignations, 1 reappointment Resignations: Christian Krings (vice-chair), Gerhard Mertes, René Thissen and Fernand Grifnée · Appointments: Joseph Backes (vice-chair), Christian Maréchal, Jean-Marie Bertrand and Thierry Wimmer · Reappointment: Xavier Drion (chair) · Board meeting of 01-03-2023 · Gazette deed
First establishment Boulevard de Patience et Beaujonc 9, Liège
All 16 events

Comparable companies

same main activity, similar in size and age
Company
MOVE Liège €506,365 €257,018 66.1% 0.7
SORELECO Uccle €478,358 €183,282 92.1% -
Dokter Prud’homme Patrick Eeklo €574,270 €316,195 80.3% -
Dr. M. Veys Bruges €249,414 €182,505 32.3% -
SANCHEZTHESIA Etterbeek €273,404 €158,531 41.0% -
Dr. Melis en Dr. Vandenbussche Bruges €365,390 €459,035 99.8% -
Behrmed Brussels €206,499 €116,788 99.2% -

These companies have the same main activity as MOVE: human health activities (NACE 86101). They are comparable in size and age: total assets between €206,000 and €574,000, founded between 2017 and 2022.

Official details

Source: KBO
Status
Active since 29-02-2020Normal situation
Registered office
15 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 9 November 2026.
Activity
Human health activitiesNACE 86101
Establishment unit
2.315.293.2954000 Liège, since 01-04-2021
Financial year end
31 December
Peppol
Reachable since 20-11-2020
Company details

Annual accounts 2025

€257,018▲ 47.4%
€184,686▲ 186%
€334,565▲ 123%
€506,365▲ 3.4%
0.7 FTE▼ 30.0%
Filing
Filed on 09-07-2026, 22 days before the end of the filing period
Financials

Insights on MOVE

Solvency rose in 2025 from 30.6% to 66.1% because of the retained profit and lower debts.

In June 2023, three directors stepped down.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

full format, filed on 09-07-2026, 22 days before the deadline
€257,018
▲ 47.4%
€185,013
▲ 185%
€184,686
▲ 186%
€334,862
▲ 123%
66.1%
▲ 35.5 percentage points
2.95
▲ 1.51

The turnover shown is an estimate from the gross margin.

Turnover ≈ €440,000. Estimated: probably between €320,000 and €760,000.

Balance sheet

balance sheet total €506,365 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

66.1%

Higher than 59% of 784 companies in 2025.

2.95

Higher than 53% of 771 companies in 2025.

36.5%

Higher than 91% of 776 companies in 2025.

MOVE Middle half of the sector 80% of the sector Full accounts in human health (NACE 86)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half · Staff: bottom quarter

Staff

€102,617

Staff costs divided by the average number of full-time equivalents.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023202220212020
Balance sheet: assets
20/58 506,365489,653407,129223,809552,232296,667
29/58 506,365489,653407,129223,809552,232296,667
40/41 338,403190,10223,02592,500503,782206,667
40 1,189-----
41 337,214190,10223,02592,500503,782206,667
54/58 165,302294,936376,792124,22533,78590,000
490/1 2,6604,6147,3117,08414,665-
Balance sheet: equity and liabilities
10/49 506,365489,653407,129223,809552,232296,667
10/15 334,565149,87985,26420,537417,601259,631
14 334,565149,87985,26420,537417,601259,631
17/49 171,800339,774321,864203,272134,63137,036
42/48 171,503339,774296,864203,272134,63137,036
44 166,082324,039271,864182,999115,73437,036
440/4 166,082324,039271,864182,999115,73437,036
45 5,4218,75918,02620,27318,897-
450/3 --1,8421,875--
454/9 5,4218,75916,18418,39818,897-
47/48 -6,9756,975---
492/3 296-25,000---
Income statement
73 642,452518,703601,624126,746291,397296,667
76A 75,0006,555109,2171,367140,000-
9900 257,018174,344174,716-288,359227,231259,631
60/61 460,434350,914426,908416,471204,16637,036
62 71,832107,470109,217106,07368,817-
640/8 -200----
66A 1731,7125312,496--
9901 185,01364,96164,968-396,928158,414259,631
65/66B 327347241136445-
65 327347241---
66B ---136445-
9903 184,68664,61564,728-397,064157,969259,631
9904 184,68664,61564,728-397,064157,969259,631
9905 184,68664,61564,728-397,064157,969259,631
Appropriation of the result
9906 334,565149,87985,26420,537417,601259,631
14P 149,87985,26420,537417,601259,631-
Social balance sheet
9087 0.71110.7-
Document PDFPDFPDFPDFPDFPDF

The notes to these accounts have 2 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 09-07-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 full format 09-07-2026 2026-00287030 PDF
31-12-2024 full format 01-07-2025 2025-00225136 PDF
31-12-2023 full format 11-07-2024 2024-00249441 PDF
31-12-2022 full format 20-09-2023 2023-00450682 PDF
31-12-2021 full format 28-06-2022 2022-20147588 PDF
31-12-2020 full format 27-06-2022 2022-20095668 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023202220212020
-129,634-81,857252,56790,440-56,215-
334,862149,879110,26420,537417,601259,631
66.1%30.6%20.9%9.2%75.6%87.5%
2.951.441.371.104.108.01
0.512.273.779.900.320.14
55.2%43.1%75.9%-37.8%100.0%
36.5%13.2%15.9%-177.4%28.6%87.5%
132 days337 days232 days160 days207 days365 days

EBIT margin: not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on MOVE

The operating result for 2025 is 185% higher than in 2024 and the highest since 2020. It is a recovery after the fall in 2024.

Debt's share of the balance-sheet total falls from 69.4% to 33.9%. Equity is higher and debt is lower.

Board & ownership

Board

20 directors, no change since 2024
Xavier Drion
Chair and director
chair in office according to the deed of 19-06-2023 director appointed by deed of 04-03-2020
Claudia Niessen
Vice-chair and director
vice-chair in office according to the deed of 10-04-2024 director appointed by deed of 04-03-2020
Joseph Backes
Vice-chair and director
vice-chair appointed by deed of 19-06-2023 director appointed by deed of 04-03-2020
Christian Maréchal
Director
appointed by deed of 19-06-2023
Jean-Marie Bertrand
Director
appointed by deed of 19-06-2023
Thierry Wimmer
Director
appointed by deed of 19-06-2023
Jean-MarieBertrand
Director
appointed by deed of 19-02-2024
ChristianKrings
Director
in office according to the deed of 19-02-2024
ChristianMaréchal
Director
in office according to the deed of 19-02-2024
ClaudiaNiessen
Director
in office according to the deed of 19-02-2024
ElisabettaCallegari
Director
in office according to the deed of 19-02-2024
ElmarKeutgen
Director
in office according to the deed of 19-02-2024
Show all 20 directors
EvelynJadin
Director
in office according to the deed of 19-02-2024
JosephBackes
Director
in office according to the deed of 19-02-2024
MicheldeLamotte
Director
in office according to the deed of 19-02-2024
PierreBaratto
Director
in office according to the deed of 19-02-2024
ThierryWimmer
Director
in office according to the deed of 19-02-2024
ValérieSaretto
Director
in office according to the deed of 19-02-2024
WilfriedNiessen
Director
in office according to the deed of 19-02-2024
XavierDrion
Director
in office according to the deed of 19-02-2024
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 22. Pouvoirs des administrateurs : pouvoirs de représentation et de signature Le Conseil d’administration, en tant qu’organe de…”
deed of 04-03-2020

Office holders in the KBO →

Mandates through the years

31 names, the dashed line is today
Show
ChristianKrings
Director
Claudia Niessen
Director, Vice-chair
ClaudiaNiessen
Director
ElisabettaCallegari
Director
ElmarKeutgen
Director
EvelynJadin
Director
Joseph Backes
Director, Vice-chair
JosephBackes
Director
MicheldeLamotte
Director
PierreBaratto
Director
ValérieSaretto
Director
Xavier Drion
Director, Chair
XavierDrion
Director
WilfriedNiessen
Director
Christian Maréchal
Director
Jean-Marie Bertrand
Director
Thierry Wimmer
Director
ChristianMaréchal
Director
Jean-MarieBertrand
Director
ThierryWimmer
Director
Christian Krings
Vice-chair
Fernand Grifnée
Director
Gerhard Mertes
Director
René Thissen
Director
Wilfried Niessen
Independent director
Elimar Keutgen
Director
Elisabetta Callegari
Director
Evelyn Jadin
Director
Michel de Lamotte
Director
Pierre Baratto
Director
Valérie Saretto
Director
LeadershipBoardEarliermandate already running before its first mentionend not dated
Mandates as a list
  • ChristianKrings
    • Director, from 19-02-2020 to date
  • Claudia Niessen
    • Director, from 19-02-2020 to date
    • Vice-chair, since before 10-04-2024
  • ClaudiaNiessen
    • Director, from 19-02-2020 to date
  • ElisabettaCallegari
    • Director, from 19-02-2020 to date
  • ElmarKeutgen
    • Director, from 19-02-2020 to date
  • EvelynJadin
    • Director, from 19-02-2020 to date
  • Joseph Backes
    • Director, from 19-02-2020 to date
    • Vice-chair, appointed by deed of 19-06-2023, still in office
  • JosephBackes
    • Director, from 19-02-2020 to date
  • MicheldeLamotte
    • Director, from 19-02-2020 to date
  • PierreBaratto
    • Director, from 19-02-2020 to date
  • ValérieSaretto
    • Director, from 19-02-2020 to date
  • Xavier Drion
    • Director, from 19-02-2020 to date
    • Chair, since before 19-06-2023
  • XavierDrion
    • Director, from 19-02-2020 to date
  • WilfriedNiessen
    • Director, from 29-06-2020 to date
  • Christian Maréchal
    • Director, appointed by deed of 19-06-2023, still in office
  • Jean-Marie Bertrand
    • Director, appointed by deed of 19-06-2023, still in office
  • Thierry Wimmer
    • Director, appointed by deed of 19-06-2023, still in office
  • ChristianMaréchal
    • Director, since before 19-02-2024
  • Jean-MarieBertrand
    • Director, appointed by deed of 19-02-2024, still in office
  • ThierryWimmer
    • Director, since before 19-02-2024
  • Christian Krings
    • Director, from 19-02-2020, ended, last mentioned on 04-03-2020
    • Vice-chair, until 19-06-2023
  • Fernand Grifnée
    • Director, from 19-02-2020 to 19-06-2023
  • Gerhard Mertes
    • Director, from 19-02-2020 to 19-06-2023
  • René Thissen
    • Director, from 19-02-2020 to 20-06-2022
  • Wilfried Niessen
    • Independent director, from 29-06-2020, last mentioned in 2020
  • Elimar Keutgen
    • Director, appointed by deed of 04-03-2020, no longer listed in the 2021 annual accounts
  • Elisabetta Callegari
    • Director, from 19-02-2020, last mentioned in 2020
  • Evelyn Jadin
    • Director, from 19-02-2020, last mentioned in 2020
  • Michel de Lamotte
    • Director, from 19-02-2020, last mentioned in 2020
  • Pierre Baratto
    • Director, from 19-02-2020, last mentioned in 2020
  • Valérie Saretto
    • Director, from 19-02-2020, last mentioned in 2020

See the board, name and registered office on a given date →

Control

Founders
Groupe santé CHC, Klinik Sankt Josef - Sankt Vith, St. Nikolaus-Hospital Eupen
This company
MOVE
Equity €334,565
Profit €184,686 in 2025

Articles of association

deed of 04-03-2020 (in French)
Board ruleThese rules set how the board is made up, meets and takes decisions.
14 directors
“7 Groupe santé CHC 3 Klinik St. Josef 3 St. Nikolaus-Hospital 1 indépendant”
Membership ruleThe articles set who can become a member or partner, and on what terms.
“Article 14/5 de la loi sur les hôpitaux et autres établissements de soins coordonnée le 10 juillet 2008, décide souverainement et sans avoir…”
“Aucun membre titulaire droit ni réclamation sur actifs du seul fait qualité membre, droits sur actifs Association”

Founders

At incorporation deed of 04-03-2020 ↗

Network & group

No group

MOVE has no parent and no holdings in its annual accounts. MOVE shares no director with another company.

At the same address

Boulevard de Patience et Beaujonc 9, 4000 Liège · 14 other companies
Groupe santé CHC
registered office since 24-09-1976 · founded in 1976
 3,991 FTE (2025)
0416.805.238
CHC New Dev
registered office since 09-12-2014 · founded in 2014
 turnover €13.3m (2025)
0506.669.107
FEDERATION REGIONALE DES ASSOCIATIONS DE TELEMATIQUE MEDICALE
registered office since 02-04-2012 · founded in 2008
 15 FTE (2025)
0898.587.313
Association des Médecins exercant au Groupe santé CHC
registered office since 01-01-2008 · founded in 1979
 11 FTE (2025)
0419.663.372
FONDS SOCIAL LUCIEN HENON
registered office since 27-08-2003 · founded in 2003
 total assets €549,836 (2025)
0860.246.676
PneumaPaidos
establishment since 14-03-2025 · founded in 2025
 total assets €53,327 (2025)
1021.035.262
Fondation CHC
registered office since 09-02-2024 · founded in 2024 · negative equity (2025)
 total assets €5,573 (2025)
1005.832.293
Fonds de recherche Lucien Hénon
registered office since 12-06-2006 · founded in 2006 · accounts filed late
 total assets €3,481 (2019)
0881.802.353
Van Stappen, Charlotte (sole trader)
establishment since 01-04-2026
 founded in 2026
0791.532.173
Khalaf, Khalil (sole trader)
establishment since 18-11-2024
 founded in 2024
1019.226.213
and 4 more

Timeline

Timeline

16 events since 2020

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBfull format · 22 days before the deadline
2025
Liquidity doubles current ratio 2.95 The current ratio rises from 1.44 to 2.95. Short-term debt falls from €339,774 to €171,503.
Annual accounts 2024 filed PDFfull format · 30 days before the deadline
2024
Annual accounts 2023 filed PDFfull format · 20 days before the deadline
3 directors reappointedXavier Drion (chair), Claudia Niessen (vice-chair) and Joseph Backes (vice-chair) · Board meeting of 26-02-20244 points ▸

Open the deed in the Belgian Official Gazette

1 director appointed, 14 reappointmentsAppointment: Jean-MarieBertrand · Reappointments: JosephBackes, PierreBaratto, Jean-MarieBertrand, ElisabettaCallegari, MicheldeLamotte, XavierDrion and 8 others · General meeting of 21-12-202317 points ▸
  • General meeting, 21-06-2023
  • Director appointment, Jean-MarieBertrand
  • General meeting, 21-12-2023
  • Director reappointment, JosephBackes
  • Director reappointment, PierreBaratto
  • Director reappointment, Jean-MarieBertrand
  • Director reappointment, ElisabettaCallegari
  • Director reappointment, MicheldeLamotte
  • Director reappointment, XavierDrion
  • Director reappointment, EvelynJadin
  • Director reappointment, ElmarKeutgen
  • Director reappointment, ChristianKrings
  • Director reappointment, ClaudiaNiessen
  • Director reappointment, WilfriedNiessen
  • Director reappointment, ChristianMaréchal
  • Director reappointment, ValérieSaretto
  • Director reappointment, ThierryWimmer

Open the deed in the Belgian Official Gazette

2023
Back to profit net €64,728 The net result is €64,728, after one loss-making year.
Annual accounts 2022 filed PDFfull format · 51 days late
4 directors appointed, 4 resignations, 1 reappointmentResignations: Christian Krings (vice-chair), Gerhard Mertes, René Thissen and Fernand Grifnée · Appointments: Joseph Backes (vice-chair), Christian Maréchal, Jean-Marie Bertrand and Thierry Wimmer · Reappointment: Xavier Drion (chair) · Board meeting of 01-03-202321 points ▸

Open the deed in the Belgian Official Gazette

2022
Weakest financial year net -€397,064 The net result drops to -€397,064, the lowest from 2020 to 2025. It recovers the following year.
Annual accounts 2021 filed PDFfull format · 33 days before the deadline
Annual accounts 2020 filed PDFfull format · 331 days late
2021
First establishment Boulevard de Patience et Beaujonc 9, Liège
2020
Registered in the Peppol Directory Reachable for e-invoices through 0208:0744592190
Appointment: Wilfried Niessen (independent director)General meeting of 29-06-20202 points ▸
  • General meeting, 29-06-2020
  • Director appointment, Wilfried Niessen (independent director)

Open the deed in the Belgian Official Gazette

IncorporationFounders: Groupe santé CHC, Klinik Sankt Josef - Sankt Vith and St. Nikolaus-Hospital Eupen · Appointments: Elisabetta Callegari, Valérie Saretto, René Thissen, Xavier Drion, Michel de Lamotte, Pierre Baratto and 7 others · Founder: Groupe santé CHC · published on 04-03-202018 points ▸

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

MOVE was incorporated on 29 February 2020 as a non-profit association by Groupe santé CHC, Klinik Sankt Josef - Sankt Vith and St. Nikolaus-Hospital Eupen.12 The board currently has 20 members.3 Total assets rose from €296,667 in 2020 to €506,365 in 2025 and headcount from 0.7 full-time equivalents in 2021 to 0.7 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 04-03-2020
  3. 3Belgian Official Gazette, 19-02-2024
  4. 4National Bank, annual accounts 2020, 2021 and 2025

Company details

Identity

Enterprise number
0744.592.190
VAT number
BE 0744.592.190
Peppol ID
0208:0744592190
Other Peppol ID
9925:BE0744592190
Legal form
Non-profit association
Status
Active, normal situation
Founded
29-02-2020
Financial year
ends on 31 December
Peppol
Reachable since 20-11-2020Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
MOVE in French
Entity type
Legal entity

Activities

NACEBEL 2025
86101 Human health activities main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
“De réaliser toutes les activités liées à, utiles ou inhérentes à la coopération entre les membres. Celles-ci peuvent être déployées de façon…”
9 activities
  1. De réaliser toutes les activités liées à, utiles ou inhérentes à la coopération entre les membres. Celles-ci peuvent être déployées de façon phasée, intégralement ou en partie, par les membres ou à l'initiative de l’Association. Cela vaut pour des activités de nature médicale ou de soins comme pour celles de nature organisationnelle ou de soutien ;
  2. Coordonner l’offre de missions de soins générales et spécialisées entre les hôpitaux du réseau en vue de répondre aux besoins de la population et d’améliorer la qualité des soins ;
  3. Garantir l’accessibilité de toutes les missions de soins locorégionales à tous les patients nécessitant ces soins, adaptés à leurs besoins ;
  4. Conclure des accords visant à répartir ou à concentrer les tâches et le travail, en ce compris les modalités d’adressage et de renvoi, pour les soins des patients au sein du réseau en vue d’assurer la continuité des soins au sein du réseau ;
  5. Fixer des accords écrits sur la mise à disposition de moyens, notamment financiers, nécessaires à l’exécution des missions du réseau ;
  6. Organiser la concertation sur les matières soumises à discussion au niveau du réseau par les hôpitaux faisant partrie du réseau ;
  7. Promouvoir en son sein des fonctions suprarégionales dans ses domaines d’expertises ;
  8. Conclure des collaborations suprarégionales distinctes, durables et juridiquement formalisées avec des points de référence au sens de la loi sur les hôpitaux ;
  9. Conclure des collaborations durables et juridiquement formalisées avec un hôpital ou une partie d’hôpital géré par le Ministère de la Défense ;
deed of 04-03-2020 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
Boulevard de Patience et Beaujonc 9 registered office 4000 Liège 01-04-2021 2.315.293.295

Buildings and parcels at the address

Ground area
4.7 ha

Location

registered office establishment The establishment unit on the map
15 companies at this address See who is registered here

Parcels

Cadastral parcelArea Buildings Height / floors
62042B0366/00S0114.7 ha - -

We would like to set cookies. That happens only with your consent. What we measure